UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings

PloS one, 2024-06, Vol.19 (6), p.e0304552

2024

Volltextzugriff (PDF)

Impact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and blood

PloS one, 2020-03, Vol.15 (3), p.e0230473-e0230473

2020

Volltextzugriff (PDF)

Changes in genital tract immune cell populations after initiation of intrauterine contraception

American journal of obstetrics and gynecology, 2014-11, Vol.211 (5), p.489.e1-489.e9

2014

Volltextzugriff (PDF)

Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptability

Frontiers in reproductive health, 2023-07, Vol.5, p.1147628-1147628

2023

Volltextzugriff (PDF)

Impact of contraceptive initiation on vaginal microbiota

American journal of obstetrics and gynecology, 2018-06, Vol.218 (6), p.622.e1-622.e10

2018

Volltextzugriff (PDF)

Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention

Advanced drug delivery reviews, 2021-09, Vol.176, p.113849-113849, Article 113849

2021

Volltextzugriff (PDF)

Spatiotemporal regulation of human IFN-ε and innate immunity in the female reproductive tract

JCI insight, 2022-09, Vol.7 (18)

2022

Volltextzugriff (PDF)

The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission

AIDS research and human retroviruses, 2019-03, Vol.35 (3), p.219-228

2019

Volltextzugriff (PDF)

The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota

AIDS (London), 2013-10, Vol.27 Suppl 1 (Supplement 1), p.S5-S15

2013

Volltextzugriff (PDF)

Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results

Contraception (Stoneham), 2021-09, Vol.104 (3), p.222-228

2021

Volltextzugriff (PDF)

Management of heterotopic pregnancy with uterine aspiration and systemic two-dose methotrexate

Contraception (Stoneham), 2021-10, Vol.104 (4), p.444-446

2021

Volltextzugriff (PDF)

Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world

Contraception (Stoneham), 2022-02, Vol.106, p.16-33

2022

Volltextzugriff (PDF)

Early pregnancy confirmation availability at crisis pregnancy centers and abortion facilities in the United States

Contraception (Stoneham), 2023-01, Vol.117, p.30-35

2023

Volltextzugriff (PDF)

Bridging the gap: advancing multipurpose prevention technologies from the lab into the hands of women

Biology of reproduction, 2020-08, Vol.103 (2), p.286-288

2020

Volltextzugriff (PDF)

Amygdalobacter indicium gen. nov., sp. nov., and Amygdalobacter nucleatus sp. nov., gen. nov.: novel bacteria from the family Oscillospiraceae isolated from the female genital tract

International journal of systematic and evolutionary microbiology, 2023-10, Vol.73 (10)

2023

Volltextzugriff (PDF)

Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials

Contraception (Stoneham), 2022-12, Vol.116, p.44-50

2022

Volltextzugriff (PDF)

Misreporting of contraceptive hormone use in clinical research participants

Contraception (Stoneham), 2018-04, Vol.97 (4), p.346-353

2018

Volltextzugriff (PDF)

Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?

Contraception (Stoneham), 2018-03, Vol.97 (3), p.191-197

2018

Volltextzugriff (PDF)

Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?

AIDS (London), 2016-11, Vol.30 (17), p.2571-2576

2016

Volltextzugriff (PDF)

Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancer

Vaccine, 2024-11, Vol.42 (25), p.126100, Article 126100

2024

Volltextzugriff (PDF)

A sensitive and robust UPLC–MS/MS method for quantitation of estrogens and progestogens in human serum

Contraception (Stoneham), 2019-04, Vol.99 (4), p.244-250

2019

Volltextzugriff (PDF)

Dextromethorphan as a novel nonopioid adjunctive agent for pain control with medication abortion: A randomized controlled trial

Contraception (Stoneham), 2023-02, Vol.118, p.109908-109908, Article 109908

2023

Volltextzugriff (PDF)

Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women

Contraception (Stoneham), 2022-12, Vol.116, p.29-36

2022

Volltextzugriff (PDF)

Effect of patient genetics on etonogestrel pharmacokinetics when combined with efavirenz or nevirapine ART

Journal of antimicrobial chemotherapy, 2019-10, Vol.74 (10), p.3003-3010

2019

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings

Impact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and blood

Changes in genital tract immune cell populations after initiation of intrauterine contraception

Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptability

Impact of contraceptive initiation on vaginal microbiota

Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention

Spatiotemporal regulation of human IFN-ε and innate immunity in the female reproductive tract

The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission

The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota

Estetrol-drospirenone combination oral contraceptive: North American phase 3 efficacy and safety results

Management of heterotopic pregnancy with uterine aspiration and systemic two-dose methotrexate

Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world

Early pregnancy confirmation availability at crisis pregnancy centers and abortion facilities in the United States

Bridging the gap: advancing multipurpose prevention technologies from the lab into the hands of women

Amygdalobacter indicium gen. nov., sp. nov., and Amygdalobacter nucleatus sp. nov., gen. nov.: novel bacteria from the family Oscillospiraceae isolated from the female genital tract

Tolerability and safety of the estetrol/drospirenone combined oral contraceptive: Pooled analysis of two multicenter, open-label phase 3 trials

Misreporting of contraceptive hormone use in clinical research participants

Understanding the public health value and defining preferred product characteristics for therapeutic human papillomavirus (HPV) vaccines: World Health Organization consultations, October 2021—March 2022

Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?

Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?

Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancer

A sensitive and robust UPLC–MS/MS method for quantitation of estrogens and progestogens in human serum

Dextromethorphan as a novel nonopioid adjunctive agent for pain control with medication abortion: A randomized controlled trial

Pooled analysis of two phase 3 trials evaluating the effects of a novel combined oral contraceptive containing estetrol/drospirenone on bleeding patterns in healthy women

Effect of patient genetics on etonogestrel pharmacokinetics when combined with efavirenz or nevirapine ART

Suchergebnisse filtern